In our previous study, we demonstrated that IL-33 serum concentration was significantly higher in patients with RA than in age-matched healthy controls, patients with primary Sjogren’s syndrome, and patients with osteoarthritis. This evidence concerns the gene IL33 and rheumatoid arthritis.